Insider · CIK 0001382225
Fred Telling
Files at OGEN (ORAGENICS INC). First filing Dec 1, 2023, latest Jan 22, 2026.
In brief
Fred Telling files SEC Form 4 as director at OGEN (ORAGENICS INC). Since Dec 1, 2023, Fred Telling has reported 0 open-market buys worth $0 and 4 open-market sells worth $14k, the latest filed on Jan 22, 2026.
A track record needs three past buys with six months of prices behind them; Fred Telling has 0, so none is measured yet.
The newest scored trade: sold $198 of OGEN on Dec 12, 2025, filed Jan 22, 2026, scored 20 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $397.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OGEN: ORAGENICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | OGENsell ORAGENICS INC | $198 210 shares | -18% | +8% from low-93% from high | |
| 15Weak | OGENsell ORAGENICS INC | $198 210 shares | -1% | +8% from low-93% from high | |
| 23Weak | ORAGENICS INC | $1,295 3,597 shares | -9% | - | |
| 15Weak | OGENsell ORAGENICS INC | $12k 3,500 shares | -8% | +37% from low-70% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 12, 2025 | OGEN Oragenics, Inc. | 210 0.01% of outstanding | $192 | Dec 12, 2025 | none |
| Dec 6, 2024 | OGEN ORAGENICS, INC. | 3,597 0.03% of outstanding | $1,294 | Dec 6, 2024 | none |
| Nov 30, 2023 | OGEN ORAGENICS, INC. | 3,500 0.14% of outstanding | $13k | Nov 30, 2023 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | OGEN ORAGENICS INC | SOpen-market sale Common Stock | -210 | $0.94 | $198 | 948 | Jan 22, 2026 |
| Dec 11, 2025 | OGEN ORAGENICS INC | AGrant or award Non-Employee Director Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jan 22, 2026 |
| Dec 12, 2025 | OGEN ORAGENICS INC | SOpen-market sale Common Stock | -210 | $0.94 | $198 | 34,538 | Dec 15, 2025 |
| Dec 11, 2025 | OGEN ORAGENICS INC | AGrant or award Non-Employee Director Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 15, 2025 |
| Dec 6, 2024 | OGEN ORAGENICS INC | SOpen-market sale Common Stock | -3,597 | $0.36 | $1,295 | 34,748 | Dec 9, 2024 |
| Nov 30, 2023 | OGEN ORAGENICS INC | SOpen-market sale Common Stock | -3,500 | $3.57 | $12k | 38,345 | Dec 1, 2023 |
Questions about Fred Telling
Answered from the filings on this page, as of the latest one.
Is Fred Telling buying or selling?
In the last 12 months Fred Telling reported 0 open-market buys worth $0 and 2 open-market sells worth $397 on SEC Form 4; the latest was sold $198 of OGEN on Dec 12, 2025. Grants, option exercises and tax withholding are not counted.
How did Fred Telling's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Fred Telling has 0.
Where does Fred Telling file Form 4?
Fred Telling has filed Form 4 at OGEN (ORAGENICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.